Study of Palivizumab in Children with High Risk of Severe Respiratory Syncytial Virus (RSV) Disease

Trial Identifier: D4800L00014
Sponsor: AstraZeneca
Start Date: December 2025
Primary Completion Date: February 2027
Study Completion Date: February 2027
Condition: Respiratory Syncytial Virus Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
IN Hyderabad, IN, 500084
IN Kanpur, IN, 208011
IN Kolkata, IN, 700073
IN Mysore, IN, 570001
IN Pune, IN, 411006
IN Vidyanagar, Hubballi, IN, 580022